1.
Association of Glucagon-Like Peptide-1 Receptor Agonists With Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 Countries.
Lakhani Moiz, Kwan Angela T H, Mihalache Andrew, Popovic Marko M, Nanji Keean, Xie Jim S et al.
Am J OphthalmolMay 202519 citationsObservational Study
This study found semaglutide is associated with increased reporting of ischemic optic neuropathy and diabetic retinopathy, highlighting the need for vigilance regarding ocular adverse events in patients using this widely prescribed drug.